Cox regression and risk competition model findings indicate that with or without hyperuricemia, elevated NT-proBNP, hs-troponinT and hs-troponinI were each significantly positively associated with the cumulative incidence of all-cause (Figures 5A–F) and cardiovascular mortality (Figures 6A–F). This evidence concerns the gene NPPB and hyperuricemia.